|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Expenses | |
| Consulting | |
| Depreciation | |
| Director’s fees and audit committee | |
| Exploration and evaluation expenditures | |
| General and administrative | |
| Indemnification support fee | |
| Insurance | |
| Listing expense | |
| Loss (gain) on foreign exchange | |
| Payroll expense | |
| Professional fees | |
| Shareholder communications | |
| Share-based compensation | |
| Transfer agent and filing fees | |
| Total expenses | |
| Net loss before other items | |
| Accretion expense of discount and interest expense on loans payable | |
| Accretion expense for asset retirement obligations | |
| Interest income | |
| Other income | |
| Unrealized loss on marketable securities | |
| Net loss | |
| Other comprehensive loss | |
| Other comprehensive loss that may be reclassified to profit or loss: | |
| Exchange differences on translating foreign operations | |
| Total comprehensive loss | |
| Loss per share - basic | |
| Loss per share - diluted | |
| Weighted average shares outstanding - basic | |
| Weighted average shares outstanding - diluted |
Loading...
